Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)

Z Gastroenterol. 2023 Feb 15. doi: 10.1055/a-1957-5671. Online ahead of print.ABSTRACTThe prevalence of fatty liver disease has increased significantly in Germany in recent years. With an estimated 18 million German citizens being affected, it is now among the most prevalent diseases. Furthermore, it is also considered a relevant and independent risk factor for other common cardiovascular diseases such as heart attack or stroke. Finally, diabetes mellitus promotes the development of and an unfavorable course of fatty liver disease. Given the high prevalence and complications, the German healthcare system is reaching its limits.Therefore, close coordination of all healthcare providers and specialists involved in the treatment of these patients is essential. In an expert consensus involving private practice and hospital doctors from the fields of gastroenterology, endocrinology, cardiology, general practitioners and laboratory physicians, as well as in close coordination with patient representatives, we have designed a concept for the care of these patients in the German healthcare system. Necessary developments are also addressed. In addition to being useful as a practical guideline, this should also support health policy work, especially in the development of practical care solutions at the medical level.PMID:36791784 | DOI:10.1055/a-1957-5671
Source: Zeitschrift fur Gastroenterologie - Category: Gastroenterology Authors: Source Type: research